Cytek Biosciences Reports Second Quarter 2026 Financial Results
| The Manila Times
FREMONT, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. ('Cytek Biosciences” or 'Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial results for the second quarter ended June 30, 2026.